中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
[1,3]苯并二噁唑并[5,6-c]-1,3-二噁唑并[4,5-i]5-氮杂菲-14(13H)-酮,5,7-二甲氧基-13-甲基- |
oxymacarpine |
125032-01-1 |
C22H17NO7 |
|
[1,3]恶嗪烷-2,6-二酮 |
Oxauracil |
5638-70-0 |
C4H5NO3 |
|
[1,3]恶唑并[5,4-d]嘧啶-7-醇 |
Oxazolo<5,4-d>pyrimidin-7-ol |
27433-54-1 |
C5H3N3O2 |
|
[1,3]恶唑并[5,4-d]嘧啶-2(1H)-酮 |
oxazolo[5,4-d]pyrimidin-2-ol |
90889-60-4 |
C5H3N3O2 |
|
[1,3]恶唑并[4,5-e]嘧啶-7-胺 |
oxazolo[5,4-<i>d</i>]pyrimidin-7-ylamine |
10325-61-8 |
C5H4N4O |
|
[1,3]恶唑并[4,5-d]嘧啶 |
oxazolo<4,5-d>pyrimidine |
42850-93-1 |
C5H3N3O |
|
[1,3]恶唑并[4,5-c]吡啶-6-羧酸 |
Oxazolo[4,5-C]pyridine-6-carboxylic acid |
711084-61-6 |
C7H4N2O3 |
|
[1,3]恶唑并[4,5-b]喹喔啉 |
Oxazolo[4,5-b]quinoxaline |
269-86-3 |
C9H5N3O |
|
[(异丙氧基硫基甲酰基硫基)硫基甲酰基硫基]硫代甲酸O-异丙基酯 |
o,o-Dipropan-2-yl pentathiotricarbonate |
5439-64-5 |
C9H14O2S5 |
|
[(异丁基氨基)氧基](苯基)甲酮 |
O-benzoyl-N-iso-butylhydroxylamine |
92787-70-7 |
C11H15NO2 |
|
[(十八烷氧基)甲基]环氧乙烷 |
octadecyl glycidyl ether |
16245-97-9 |
C21H42O2 |
|
[(仲-丁基氨基)氧基](苯基)甲酮 |
O-benzoyl-N-sec-butylhydroxylamine |
145279-67-0 |
C11H15NO2 |
|
[(二乙氧基硫代膦酰)氧基]乙酸乙酯 |
O,O-diethyl-O-carbethoxymethylthiophosphate |
5823-25-6 |
C8H17O5PS |
|
[(Z)-2-溴-1-(2,4-二氯苯基)乙烯基]二甲基磷酸酯 |
O,O-dimethyl-O-<1-(2,4-dichlorophenyl)-2-bromo>vinyl phosphate (isomer Z) |
68107-01-7 |
C10H10BrCl2O4P |
|
[(Z)-1-(2-溴-4-氯苯基)-2-氯乙烯氧基]-二乙氧基-巯基膦烷 |
O-(1-(4-Bromo-2-chlorophenyl)-2-chloroethenyl) O,O-diethyl phosphorothioate |
2082-40-8 |
C12H14BrCl2O3PS |
|
[(E)-十八碳-9-烯酰基](E)-十八碳-9-烯酸酯 |
Octadec-9-enoyl octadec-9-enoate |
6085-36-5 |
C36H66O3 |
|
[(E)-3-乙酰氧基-5-[3-(3-乙酰氧基-6-氧代-2,3-二氢吡喃-2-基)环氧乙烷-2-基]戊-4-烯-2-基]乙酸酯 |
Olguine |
73413-68-0 |
C18H22O9 |
|
[(E)-2-氯-1-(2,4-二溴苯基)乙烯氧基]-二甲氧基-硫基膦烷 |
O-(2-Chloro-1-(2,4-dibromophenyl)ethenyl) O,O-dimethyl phosphorodithioate |
1217-96-5 |
C10H10Br2ClO3PS |
|
[(8R,9S,10R,13S,14S,17S)-10,13-二甲基-3-氧代-1,2,6,7,8,9,11,12,14,15,16,17-十二氢环戊烯并[a]菲-17-基]己酸酯 |
O-Hexanoyl-testosteron |
10312-45-5 |
C25H38O3 |
|
[(5-苯基吡啶-2-基)氨基]乙酸酯 |
O-acetyl-N-(5-phenyl-2-pyridyl)hydroxylamine |
124392-12-7 |
C13H12N2O2 |
|
[(2R,3R,4S)-2-(6-氨基嘌呤-9-基)-4-(羟基甲基)氧杂环丁-3-基]甲醇 |
(-)-oxetanocin |
103913-16-2 |
C10H13N5O3 |
|
[(2R)-3-戊炔-2-基氧基]苯 |
o-(1-Methyl-butin-2-yl)-phenol |
1128-01-4 |
C11H12O |
|
[(2-苯甲酰氨基乙酰基)氨基] 2,2-二甲基丙酸酯 |
O-Pivaloylhippurhydroxamat |
61650-23-5 |
C14H18N2O4 |
|
[(2-羟基苯甲酰基)氨基] N-苯基氨基甲酸酯 |
o-Phenylcarbamoyl-salicylhydroxamsaeure |
65369-89-3 |
C14H12N2O4 |
|
[(1R,6S,7S,8R,9R)-4-(3,4-二羟基苯基)-9-(羟基甲基)-7-[(2S,3R,4R,5S,6S)-3,4,5-三羟基-6-甲基-四氢吡喃-2-基]氧基-2,5,10-三氧杂双环[4.4.0]癸-8-基] (E)-3-(3,4-二羟基苯基)丙-2-烯酸酯 |
orobanchoside |
61276-16-2 |
C29H34O15 |
|
[(1R,5S)-8-甲基-8-氮杂双环[3.2.1]辛烷-3-基]3-羟基-2-(羟基甲基)-2-苯丙酸酯 |
Oxymethylatropine |
2515-36-8 |
C18H25NO4 |
|
O,O’-二乙基-(2-琥珀酸二乙酯基)膦酸酯 |
diethyl 2-(diethoxyphosphoryl)succinate |
7071-15-0 |
C12H23O7P |
|
Ox吲哚-4-硼酸频那醇酯 |
4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one |
1150271-44-5 |
C14H18BNO3 |
|
OtBu-L-谷氨酸甲酯盐酸盐 |
L-glutamic acid 5-tert-butyl 1-methyl ester hydrochloride |
6234-01-1 |
C10H19NO4*ClH |
|
Orteronel; 6-[(7S)-7-羟基-6,7-二氢-5H-吡咯并[1,2-c]咪唑-7-基]-N-甲基-2-萘甲酰胺 |
Orteronel |
566939-85-3 |
C18H17N3O2 |
|
Org24598锂盐;R-(-)-N-甲基-N-[(3R)-3-苯基-3-[4-(三氟甲基)苯氧基]丙基]甘氨酸锂 |
Org 24598 lithium salt |
722456-08-8 |
C19H19F3LiNO3 |
|
Oprozomib(ONX-0912)抑制剂 |
oprozomib |
935888-69-0 |
C25H32N4O7S |
|
Oplopanone; 10alpha-羟基日本刺参萜-4-酮 |
oplopanone |
1911-78-0 |
C15H26O2 |
|
Oplodiol; (1S,4R,4aR,8aR)-1,2,3,4,4a,5,8,8a-八氢-1,4a-二甲基-7-(1-甲基乙基)-1,4-二羟基萘 |
1β,4β-dihydroxy-trans-eudesm-7-ene |
13902-62-0 |
C15H26O2 |
|
Omi/HtrA2蛋白酶抑制剂,Ucf-101 |
High Temperature Requirement A2 Inhibitor I |
313649-08-0 |
C27H17N3O5S |
|
Oleoside; (2S,3E,4S)-5-羧基-3-亚乙基-2-(beta-D-吡喃葡萄糖氧基)-3,4-二氢-2H-吡喃-4-乙酸 |
oleoside |
178600-68-5 |
C16H22O11 |
|
Olcegepant; N-[2-[5-氨基-1(S)-[4-(4-吡啶基)哌嗪-1-甲酰基]戊基氨基]-1(R)-(3,5-二溴-4-羟基苄基)-2-氧代乙基]-4-(2-氧代-1,2,3,4-四氢喹唑啉-3-基)哌啶-1-甲酰胺 |
Olcegepant |
204697-65-4 |
C38H47Br2N9O5 |
|
Odanacatib中间体 |
ethyl 2-amino-4-methylpent-4-enoate |
68843-73-2 |
C8H15NO2 |
|
Octahydroazocine盐酸盐 |
azocane hydrochloride |
36520-41-9 |
C7H15N*ClH |
|
Oblongine;(S)-1,2,3,4-四氢-8-羟基-1-[(4-羟基苯基)甲基]-7-甲氧基-2,2-二甲基异喹啉 |
(1S)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-8-ol |
60008-01-7 |
C19H24NO3+ |
|
OZANIMOD中间体 |
(R)-tert-butyl 4-cyano-2,3-dihydro-1H-inden-1-ylcarbamate |
1306763-30-3 |
C15H18N2O2 |
|
OZ439标准品 |
4-(2-(4-(dispiro[adamantane-2,3'-[1,2,4]trioxolane-5',1''-cyclohexan]-4''-yl)phenoxy)ethyl)morpholine |
1029939-86-3 |
C28H39NO5 |
|
OSI-027; 反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-f][1,2,4]三嗪-7-基]环己烷羧酸 |
OSI-027 |
936890-98-1 |
C21H22N6O3 |
|
OSI 420; 2-[[4-[(3-乙炔基苯基)氨基]-7-(2-甲氧基乙氧基)-6-喹唑啉基]氧]乙醇盐酸盐 |
2-[4-(3-Ethynyl-phenylamino)-7-(2-methoxy-ethoxy)-quinazolin-6-yloxy]-ethanol hydrochloride |
183320-51-6 |
C21H21N3O4*ClH |
|
OPC-920257中间体 |
L-leucyl-L-phenylalanine methyl ester |
38155-18-9 |
C16H24N2O3 |
|
OO-叔-丁基 O-环己基过氧碳酸酯 |
percarbonate de O,O-t-butyl et O-cyclohexyl |
21690-93-7 |
C11H20O4 |
|
ONX-0914(PR-957)抑制剂 |
Onx-0914 (PR-957) |
960374-59-8 |
C31H40N4O7 |
|
ONO 8711; (5Z)-6-[(2R,3S)-3-[[[(4-氯-2-甲基苯基)磺酰基]氨基]甲基]双环[2.2.2]辛-2-基]-5-己烯酸 |
6-[(2R,3S)-3-[[[(4-chloro-2-methylphenyl)sulfonyl]amino]methyl]bicyclo[2.2.2]oct-2-yl]-5Z-hexenoic acid |
216158-34-8 |
C22H30ClNO4S |
|
OMEGA-芋螺毒素MVIIC |
omega-Conotoxin-mviic |
147794-23-8 |
C106H178N40O32S7 |
|
OMEGA-芋螺毒素GVIA |
(1R,4S,8R,10S,13S,16S,19S,22S,25R,30R,33S,36S,39S,42S,45S,47R,51S,54R,57S,60S,63R,68R,71S,74S,78R,80S,86S,89S)-68-amino-36,71-bis(4-aminobutyl)-N-[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-22,51-bis(2-amino-2-oxoethyl)-33,60-bis[3-(diaminomethylideneamino)propyl]-8,47,78-trihydroxy-13,39-bis[(1R)-1-hydroxyethyl]-4,16,57,74,86,89-hexakis(hydroxymethyl)-19,42-bis[(4-hydroxyphenyl)methyl]-2,5,11,14,17,20,23,32,35,38,41,44,50,53,56,59,62,69,72,75,81,84,87,90,97-pentacosaoxo-27,28,65,66,93,94-hexathia-3,6,12,15,18,21,24,31,34,37,40,43,49,52,55,58,61,70,73,76,82,85,88,91,96-pentacosazahexacyclo[52.37.4.225,63.06,10.045,49.076,80]heptanonacontane-30-carboxamide |
—— |
C120H182N38O43S6 |
|